{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:58:44Z","timestamp":1776765524113,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472891"],"award-info":[{"award-number":["82472891"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Program of Zhejiang Province Natural Science Foundation of China","award":["LZ24H160001"],"award-info":[{"award-number":["LZ24H160001"]}]},{"name":"Medical Interdisciplinary Innovation Program 2024, Zhejiang University School of Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03167-7","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:39:31Z","timestamp":1738388371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Simultaneously delivery of functional gallium ions and hydrogen sulfide to endow potentiated treatment efficacy in chemo- and PARPi-resistant ovarian cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Sangsang","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenglong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixuan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"3167_CR1","doi-asserted-by":"publisher","unstructured":"Van Nyen T, Planque M, van Wagensveld L, Duarte JAG, Zaal EA, Talebi A, Rossi M, K\u00f6rner PR, Rizzotto L, Moens S, et al. Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers. Nat Commun. 2022;13. https:\/\/doi.org\/10.1038\/s41467-022-32272-6.","DOI":"10.1038\/s41467-022-32272-6"},{"key":"3167_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Stat 2021 CA: cancer J Clin. 2021;71:7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","journal-title":"Cancer Stat 2021 CA: cancer J Clin"},{"key":"3167_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM. Epithelial ovarian cancer: evolution of management in the era of precision medicine. Cancer J Clin. 2019;69:280\u2013304. https:\/\/doi.org\/10.3322\/caac.21559.","journal-title":"Cancer J Clin"},{"key":"3167_CR4","doi-asserted-by":"publisher","first-page":"m3773","DOI":"10.1136\/bmj.m3773","volume":"371","author":"L Kuroki","year":"2020","unstructured":"Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ (Clinical Res ed). 2020;371:m3773. https:\/\/doi.org\/10.1136\/bmj.m3773.","journal-title":"BMJ (Clinical Res ed)"},{"key":"3167_CR5","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/s0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393:1240\u201353. https:\/\/doi.org\/10.1016\/s0140-6736(18)32552-2.","journal-title":"Lancet"},{"key":"3167_CR6","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31:1869\u201383. https:\/\/doi.org\/10.1038\/onc.2011.384.","journal-title":"Oncogene"},{"key":"3167_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.clon.2020.03.005","volume":"32","author":"MW Wong-Brown","year":"2020","unstructured":"Wong-Brown MW, van der Westhuizen A, Bowden NA. Targeting DNA repair in Ovarian Cancer Treatment Resistance. Clin Oncol (R Coll Radiol (G B)). 2020;32:518\u201326. https:\/\/doi.org\/10.1016\/j.clon.2020.03.005.","journal-title":"Clin Oncol (R Coll Radiol (G B))"},{"key":"3167_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"PG Pili\u00e9","year":"2019","unstructured":"Pili\u00e9 PG, Tang C, Mills GB, Yap TA. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat Rev Clin Oncol. 2019;16:81\u2013104. https:\/\/doi.org\/10.1038\/s41571-018-0114-z.","journal-title":"Nat Rev Clin Oncol"},{"key":"3167_CR9","doi-asserted-by":"publisher","first-page":"e2313670","DOI":"10.1002\/adma.202313670","volume":"36","author":"B Geng","year":"2024","unstructured":"Geng B, Hu J, He X, Zhang Z, Cai J, Pan D, Shen L. Single atom catalysts remodel Tumor Microenvironment for Augmented Sonodynamic Immunotherapy. Adv Mater. 2024;36:e2313670. https:\/\/doi.org\/10.1002\/adma.202313670.","journal-title":"Adv Mater"},{"key":"3167_CR10","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1038\/s41467-022-33474-8","volume":"13","author":"B Geng","year":"2022","unstructured":"Geng B, Hu J, Li Y, Feng S, Pan D, Feng L, Shen L. Near-infrared phosphorescent carbon dots for sonodynamic precision tumor therapy. Nat Commun. 2022;13:5735. https:\/\/doi.org\/10.1038\/s41467-022-33474-8.","journal-title":"Nat Commun"},{"key":"3167_CR11","doi-asserted-by":"publisher","first-page":"213212","DOI":"10.1016\/j.ccr.2020.213212","volume":"409","author":"A Pandey","year":"2020","unstructured":"Pandey A, Dhas N, Deshmukh P, Caro C, Patil P, Luisa Garc\u00eda-Mart\u00edn M, Padya B, Nikam A, Mehta T, Mutalik S. Heterogeneous surface architectured metal-organic frameworks for cancer therapy, imaging, and biosensing: a state-of-the-art review. Coord Chem Rev. 2020;409:213212. https:\/\/doi.org\/10.1016\/j.ccr.2020.213212.","journal-title":"Coord Chem Rev"},{"key":"3167_CR12","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.2217\/nnm-2023-0202","volume":"18","author":"WJ Chan","year":"2023","unstructured":"Chan WJ, Urandur S, Li H, Goudar VS. Recent advances in copper sulfide nanoparticles for phototherapy of bacterial infections and cancer. Nanomed (Lond). 2023;18:2185\u2013204. https:\/\/doi.org\/10.2217\/nnm-2023-0202.","journal-title":"Nanomed (Lond)"},{"key":"3167_CR13","doi-asserted-by":"publisher","first-page":"119513","DOI":"10.1016\/j.ijpharm.2020.119513","volume":"585","author":"Y Nie","year":"2020","unstructured":"Nie Y, Li D, Peng Y, Wang S, Hu S, Liu M, Ding J, Zhou W. Metal organic framework coated MnO2 nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer. Int J Pharm. 2020;585:119513. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119513.","journal-title":"Int J Pharm"},{"key":"3167_CR14","doi-asserted-by":"publisher","first-page":"103981","DOI":"10.1016\/j.drudis.2024.103981","volume":"29","author":"J Dai","year":"2024","unstructured":"Dai J, Ashrafizadeh M, Aref AR, Sethi G, Ertas YN. Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy. Drug Discovery Today. 2024;29:103981. https:\/\/doi.org\/10.1016\/j.drudis.2024.103981.","journal-title":"Drug Discovery Today"},{"key":"3167_CR15","doi-asserted-by":"publisher","first-page":"e202308413","DOI":"10.1002\/anie.202308413","volume":"62","author":"W Chen","year":"2023","unstructured":"Chen W, Li Y, Liu C, Kang Y, Qin D, Chen S, Zhou J, Liu HJ, Ferdows BE, Patel DN, et al. (\u03b2-Elemene@Stanene) strategy for enhanced Cancer Chemo-Immunotherapy. Angew Chem Int Ed Engl. 2023;62:e202308413. https:\/\/doi.org\/10.1002\/anie.202308413. situ Engineering of Tumor-Associated Macrophages via a Nanodrug-Delivering-Drug.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3167_CR16","doi-asserted-by":"publisher","first-page":"101564","DOI":"10.1016\/j.redox.2020.101564","volume":"34","author":"H Li","year":"2020","unstructured":"Li H, Xu F, Gao G, Gao X, Wu B, Zheng C, Wang P, Li Z, Hua H, Li D. Hydrogen sulfide and its donors: Novel Antitumor and antimetastatic therapies for triple-negative breast cancer. Redox Biol. 2020;34:101564. https:\/\/doi.org\/10.1016\/j.redox.2020.101564.","journal-title":"Redox Biol"},{"key":"3167_CR17","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1089\/ars.2016.6909","volume":"26","author":"GK Kolluru","year":"2017","unstructured":"Kolluru GK, Shen X, Yuan S, Kevil CG. Gasotransmitter Heterocellular Signal Antioxid Redox Signal. 2017;26:936\u201360. https:\/\/doi.org\/10.1089\/ars.2016.6909.","journal-title":"Gasotransmitter Heterocellular Signal Antioxid Redox Signal"},{"key":"3167_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1089\/ars.2013.5308","volume":"20","author":"K Kashfi","year":"2014","unstructured":"Kashfi K. Anti-cancer activity of new designer hydrogen sulfide-donating hybrids. Antioxid Redox Signal. 2014;20:831\u201346. https:\/\/doi.org\/10.1089\/ars.2013.5308.","journal-title":"Antioxid Redox Signal"},{"key":"3167_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.7150\/ijbs.47850","volume":"17","author":"EE Ngowi","year":"2021","unstructured":"Ngowi EE, Afzal A, Sarfraz M, Khattak S, Zaman SU, Khan NH, Li T, Jiang QY, Zhang X, Duan SF, et al. Role of hydrogen sulfide donors in cancer development and progression. Int J Biol Sci. 2021;17:73\u201388. https:\/\/doi.org\/10.7150\/ijbs.47850.","journal-title":"Int J Biol Sci"},{"key":"3167_CR20","doi-asserted-by":"publisher","unstructured":"Marutani E, Morita M, Hirai S, Kai S, Grange RMH, Miyazaki Y, Nagashima F, Traeger L, Magliocca A, Ida T, et al. Sulfide catabolism ameliorates hypoxic brain injury. Nat Commun. 2021;12. https:\/\/doi.org\/10.1038\/s41467-021-23363-x.","DOI":"10.1038\/s41467-021-23363-x"},{"key":"3167_CR21","doi-asserted-by":"publisher","first-page":"1903512","DOI":"10.1002\/advs.201903512","volume":"7","author":"C Xie","year":"2020","unstructured":"Xie C, Cen D, Ren Z, Wang Y, Wu Y, Li X, Han G, Cai X. FeS@BSA Nanoclusters to enable H(2)S-Amplified ROS-Based therapy with MRI Guidance. Adv Sci (Weinh). 2020;7:1903512. https:\/\/doi.org\/10.1002\/advs.201903512.","journal-title":"Adv Sci (Weinh)"},{"key":"3167_CR22","doi-asserted-by":"publisher","first-page":"e2104037","DOI":"10.1002\/adma.202104037","volume":"33","author":"D Cen","year":"2021","unstructured":"Cen D, Ge Q, Xie C, Zheng Q, Guo J, Zhang Y, Wang Y, Li X, Gu Z, Cai X. ZnS@BSA Nanoclusters Potentiate Efficacy of Cancer Immunotherapy. Advanced materials (Deerfield Beach. Fla). 2021;33:e2104037. https:\/\/doi.org\/10.1002\/adma.202104037.","journal-title":"Fla)"},{"key":"3167_CR23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.tibtech.2020.10.005","volume":"39","author":"W Xie","year":"2021","unstructured":"Xie W, Allioux FM, Ou JZ, Miyako E, Tang SY, Kalantar-Zadeh K. Gallium-based Liquid Metal particles for therapeutics. Trends Biotechnol. 2021;39:624\u201340. https:\/\/doi.org\/10.1016\/j.tibtech.2020.10.005.","journal-title":"Trends Biotechnol"},{"key":"3167_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.phrs.2016.11.009","volume":"115","author":"CR Chitambar","year":"2017","unstructured":"Chitambar CR. The therapeutic potential of iron-targeting gallium compounds in human disease: from basic research to clinical application. Pharmacol Res. 2017;115:56\u201364. https:\/\/doi.org\/10.1016\/j.phrs.2016.11.009.","journal-title":"Pharmacol Res"},{"key":"3167_CR25","doi-asserted-by":"publisher","first-page":"111309","DOI":"10.1016\/j.jinorgbio.2020.111309","volume":"214","author":"N Kircheva","year":"2021","unstructured":"Kircheva N, Dudev T. Competition between abiogenic and biogenic metal cations in biological systems: mechanisms of gallium\u2019s anticancer and antibacterial effect. J Inorg Biochem. 2021;214:111309. https:\/\/doi.org\/10.1016\/j.jinorgbio.2020.111309.","journal-title":"J Inorg Biochem"},{"key":"3167_CR26","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1021\/acs.jpcb.9b03145","volume":"123","author":"N Kircheva","year":"2019","unstructured":"Kircheva N, Dudev T. Novel insights into Gallium\u2019s mechanism of therapeutic action: a DFT\/PCM study of the Interaction between Ga(3+) and Ribonucleotide Reductase substrates. J Phys Chem B. 2019;123:5444\u201351. https:\/\/doi.org\/10.1021\/acs.jpcb.9b03145.","journal-title":"J Phys Chem B"},{"key":"3167_CR27","doi-asserted-by":"publisher","unstructured":"Mostafa N, Salem A, Mansour SZ, El-Sonbaty SM, Moawed FSM, Kandil EI. Rationale for Tailoring an Alternative Oncology Trial Using a Novel Gallium-Based Nanocomplex: Mechanistic Insights and Preclinical Challenges. Technology in cancer research & treatment. 2022;21, 15330338221085376. https:\/\/doi.org\/10.1177\/15330338221085376","DOI":"10.1177\/15330338221085376"},{"key":"3167_CR28","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.3390\/ijerph7052337","volume":"7","author":"CR Chitambar","year":"2010","unstructured":"Chitambar CR. Medical applications and toxicities of gallium compounds. Int J Environ Res Public Health. 2010;7:2337\u201361. https:\/\/doi.org\/10.3390\/ijerph7052337.","journal-title":"Int J Environ Res Public Health"},{"key":"3167_CR29","doi-asserted-by":"publisher","first-page":"10557","DOI":"10.1002\/adma.201600038","volume":"28","author":"Q Chen","year":"2016","unstructured":"Chen Q, Liu Z. Albumin carriers for Cancer Theranostics: a conventional platform with New Promise. Adv Mater (Deerfield Beach Fla). 2016;28:10557\u201366. https:\/\/doi.org\/10.1002\/adma.201600038.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"3167_CR30","doi-asserted-by":"publisher","unstructured":"Li Y, Cen Y, Tu M, Xiang Z, Tang S, Lu W, Zhang H, Xu J. (2023). Nanoengineered Gallium Ion Incorporated Formulation for safe and efficient reversal of PARP Inhibition and Platinum Resistance in Ovarian Cancer. Research (Wash D C) 6, 0070. https:\/\/doi.org\/10.34133\/research.0070","DOI":"10.34133\/research.0070"},{"key":"3167_CR31","doi-asserted-by":"publisher","first-page":"12786","DOI":"10.1021\/acsnano.2c04956","volume":"16","author":"Y Li","year":"2022","unstructured":"Li Y, Cen Y, Fang Y, Tang S, Li S, Ren Y, Zhang H, Lu W, Xu J. Breaking the Iron Homeostasis: a trojan horse self-assembled Nanodrug sensitizes homologous recombination proficient ovarian Cancer cells to PARP inhibition. ACS Nano. 2022;16:12786\u2013800. https:\/\/doi.org\/10.1021\/acsnano.2c04956.","journal-title":"ACS Nano"},{"key":"3167_CR32","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/cas.13947","volume":"110","author":"L Wang","year":"2019","unstructured":"Wang L, Yang C, Xie C, Jiang J, Gao M, Fu L, Li Y, Bao X, Fu H, Lou L. Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials. Cancer Sci. 2019;110:1064\u201375. https:\/\/doi.org\/10.1111\/cas.13947.","journal-title":"Cancer Sci"},{"key":"3167_CR33","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1016\/j.bbagen.2013.06.018","volume":"1830","author":"W Bal","year":"2013","unstructured":"Bal W, Soko\u0142owska M, Kurowska E, Faller P. Binding of transition metal ions to albumin: sites, affinities and rates. Biochim Biophys Acta. 2013;1830:5444\u201355. https:\/\/doi.org\/10.1016\/j.bbagen.2013.06.018.","journal-title":"Biochim Biophys Acta"},{"key":"3167_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/nnm.16.5","volume":"11","author":"N Hoshyar","year":"2016","unstructured":"Hoshyar N, Gray S, Han H, Bao G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomed (Lond). 2016;11:673\u201392. https:\/\/doi.org\/10.2217\/nnm.16.5.","journal-title":"Nanomed (Lond)"},{"key":"3167_CR35","doi-asserted-by":"publisher","first-page":"100672","DOI":"10.1016\/j.mtbio.2023.100672","volume":"20","author":"M Azizi","year":"2023","unstructured":"Azizi M, Jahanban-Esfahlan R, Samadian H, Hamidi M, Seidi K, Dolatshahi-Pirouz A, Yazdi AA, Shavandi A, Laurent S, Hagh BO, M., et al. Multifunctional nanostructures: Intelligent design to overcome biological barriers. Mater Today Bio. 2023;20:100672. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100672.","journal-title":"Mater Today Bio"},{"key":"3167_CR36","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.2147\/ijn.S255874","volume":"15","author":"T Park","year":"2020","unstructured":"Park T, Lee S, Amatya R, Cheong H, Moon C, Kwak HD, Min KA, Shin MC. ICG-Loaded PEGylated BSA-Silver nanoparticles for effective Photothermal Cancer Therapy. Int J Nanomed. 2020;15:5459\u201371. https:\/\/doi.org\/10.2147\/ijn.S255874.","journal-title":"Int J Nanomed"},{"key":"3167_CR37","doi-asserted-by":"publisher","unstructured":"Wang Y, Wu Y, Liu Y, Shen J, Lv L, Li L, Yang L, Zeng J, Wang Y, Zhang LW et al. (2016). BSA-Mediated synthesis of Bismuth Sulfide Nanotheranostic Agents for Tumor Multimodal Imaging and Thermoradiotherapy. 26, 5335\u201344. https:\/\/doi.org\/10.1002\/adfm.201601341","DOI":"10.1002\/adfm.201601341"},{"key":"3167_CR38","doi-asserted-by":"publisher","unstructured":"Catal\u00e1n-G\u00f3mez S, Redondo-Cubero A, Palomares FJ, Nucciarelli F, Pau JL. Tunable plasmonic resonance of gallium nanoparticles by thermal oxidation at low temperaturas. Nanotechnology. 2017;28. https:\/\/doi.org\/10.1088\/1361-6528\/aa8505.","DOI":"10.1088\/1361-6528\/aa8505"},{"key":"3167_CR39","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.scib.2020.10.021","volume":"66","author":"J Yang","year":"2021","unstructured":"Yang J, Ding L, Yu L, Wang Y, Ge M, Jiang Q, Chen Y. Nanomedicine enables autophagy-enhanced cancer-cell ferroptosis. Sci Bull. 2021;66:464\u201377. https:\/\/doi.org\/10.1016\/j.scib.2020.10.021.","journal-title":"Sci Bull"},{"key":"3167_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","volume":"82","author":"E Boedtkjer","year":"2020","unstructured":"Boedtkjer E, Pedersen SF. The acidic Tumor Microenvironment as a driver of Cancer. Annu Rev Physiol. 2020;82:103\u201326. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034627.","journal-title":"Annu Rev Physiol"},{"key":"3167_CR41","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/0008-5472.Can-12-2796","volume":"73","author":"V Estrella","year":"2013","unstructured":"Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, et al. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013;73:1524\u201335. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-2796.","journal-title":"Cancer Res"},{"key":"3167_CR42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10555-014-9506-4","volume":"33","author":"S Peppicelli","year":"2014","unstructured":"Peppicelli S, Bianchini F, Calorini L. Extracellular acidity, a reappreciated trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. Cancer Metastasis Rev. 2014;33:823\u201332. https:\/\/doi.org\/10.1007\/s10555-014-9506-4.","journal-title":"Cancer Metastasis Rev"},{"key":"3167_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cmet.2016.07.015","volume":"24","author":"X Xue","year":"2016","unstructured":"Xue X, Ramakrishnan SK, Weisz K, Triner D, Xie L, Attili D, Pant A, Gy\u0151rffy B, Zhan M, Carter-Su C, et al. Iron Uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling to promote colorectal tumorigenesis. Cell Metabol. 2016;24:447\u201361. https:\/\/doi.org\/10.1016\/j.cmet.2016.07.015.","journal-title":"Cell Metabol"},{"key":"3167_CR44","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer. 2013;13:342\u201355. https:\/\/doi.org\/10.1038\/nrc3495.","journal-title":"Nat Rev Cancer"},{"key":"3167_CR45","doi-asserted-by":"publisher","first-page":"45156","DOI":"10.1021\/acsami.2c12102","volume":"14","author":"L Souza","year":"2022","unstructured":"Souza L, Ferreira FV, Lopes JH, Camilli JA, Martin RA. Cancer Inhibition and in vivo osteointegration and compatibility of Gallium-Doped Bioactive glasses for Osteosarcoma Applications. ACS Appl Mater Interfaces. 2022;14:45156\u201366. https:\/\/doi.org\/10.1021\/acsami.2c12102.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3167_CR46","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.bbamcr.2016.04.027","volume":"1863","author":"CR Chitambar","year":"2016","unstructured":"Chitambar CR. Gallium and its competing roles with iron in biological systems. Biochim Biophys Acta. 2016;1863:2044\u201353. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.04.027.","journal-title":"Biochim Biophys Acta"},{"key":"3167_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/cbr.2015.1921","volume":"31","author":"X Lin","year":"2016","unstructured":"Lin X, Liao Y, Chen X, Long D, Yu T, Shen F. Regulation of Oncoprotein 18\/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer cells. Cancer Biother Radiopharm. 2016;31:37\u201343. https:\/\/doi.org\/10.1089\/cbr.2015.1921.","journal-title":"Cancer Biother Radiopharm"},{"key":"3167_CR48","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejmech.2017.04.009","volume":"134","author":"J Qi","year":"2017","unstructured":"Qi J, Deng J, Qian K, Tian L, Li J, He K, Huang X, Cheng Z, Zheng Y, Wang Y. Novel 2-pyridinecarboxaldehyde thiosemicarbazones Ga(III) complexes with a high antiproliferative activity by promoting apoptosis and inhibiting cell cycle. Eur J Med Chem. 2017;134:34\u201342. https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.009.","journal-title":"Eur J Med Chem"},{"key":"3167_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3892\/ijo.2015.3256","volume":"48","author":"Y Sun","year":"2016","unstructured":"Sun Y, Guan Z, Liang L, Cheng Y, Zhou J, Li J, Xu Y. NF-\u03baB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression. Int J Oncol. 2016;48:225\u201334. https:\/\/doi.org\/10.3892\/ijo.2015.3256.","journal-title":"Int J Oncol"},{"key":"3167_CR50","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1038\/onc.2016.75","volume":"35","author":"AR \u00d6ze\u015f","year":"2016","unstructured":"\u00d6ze\u015f AR, Miller DF, \u00d6ze\u015f ON, Fang F, Liu Y, Matei D, Huang T, Nephew KP. NF-\u03baB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene. 2016;35:5350\u201361. https:\/\/doi.org\/10.1038\/onc.2016.75.","journal-title":"Oncogene"},{"key":"3167_CR51","doi-asserted-by":"publisher","first-page":"e2874","DOI":"10.1038\/cddis.2017.271","volume":"8","author":"CM Kuang","year":"2017","unstructured":"Kuang CM, Fu X, Hua YJ, Shuai WD, Ye ZH, Li Y, Peng QH, Li YZ, Chen S, Qian CN, et al. BST2 confers cisplatin resistance via NF-\u03baB signaling in nasopharyngeal cancer. Cell Death Dis. 2017;8:e2874. https:\/\/doi.org\/10.1038\/cddis.2017.271.","journal-title":"Cell Death Dis"},{"key":"3167_CR52","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s12276-022-00847-4","volume":"54","author":"E Ju","year":"2022","unstructured":"Ju E, Park KA, Shen HM, Hur GM. The resurrection of RIP kinase 1 as an early cell death checkpoint regulator-a potential target for therapy in the necroptosis era. Exp Mol Med. 2022;54:1401\u201311. https:\/\/doi.org\/10.1038\/s12276-022-00847-4.","journal-title":"Exp Mol Med"},{"key":"3167_CR53","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1016\/j.molcel.2024.08.035","volume":"84","author":"H Zheng","year":"2024","unstructured":"Zheng H, Chen H, Cai Y, Shen M, Li X, Han Y, Deng X, Cao H, Liu J, Li H, et al. Hydrogen sulfide-mediated persulfidation regulates homocysteine metabolism and enhances ferroptosis in non-small cell lung cancer. Mol Cell. 2024;84:4016\u2013e40304016. https:\/\/doi.org\/10.1016\/j.molcel.2024.08.035.","journal-title":"Mol Cell"},{"key":"3167_CR54","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40265-021-01541-x","volume":"81","author":"A Lee","year":"2021","unstructured":"Lee A. Fuzuloparib: first approval. Drugs. 2021;81:1221\u20136. https:\/\/doi.org\/10.1007\/s40265-021-01541-x.","journal-title":"Drugs"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03167-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:39:40Z","timestamp":1738388380000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03167-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3167"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03167-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee (IACUC) of Zhejiang Chinese Medical University (Hangzhou, China; approval no. IACUC-20220425-12).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}